Literature DB >> 26779779

Substrate stiffness modulates lung cancer cell migration but not epithelial to mesenchymal transition.

V C Shukla1, N Higuita-Castro2, P Nana-Sinkam3, S N Ghadiali1,3,2.   

Abstract

Biomechanical properties of the tumor microenvironment, including matrix/substrate stiffness, play a significant role in tumor evolution and metastasis. Epithelial to Mesenchymal Transition (EMT) is a fundamental biological process that is associated with increased cancer cell migration and invasion. The goal of this study was to investigate (1) how substrate stiffness modulates the migration behaviors of lung adenocarcinoma cells (A549) and (2) if stiffness-induced changes in cell migration correlate with biochemical markers of EMT. Collagen-coated polydimethylsiloxane (PDMS) substrates and an Ibidi migration assay were used to investigate how substrate stiffness alters the migration patterns of A549 cells. RT-PCR, western blotting and immunofluorescence were used to investigate how substrate stiffness alters biochemical markers of EMT, that is, E-cadherin and N-cadherin, and the phosphorylation of focal adhesion proteins. Increases in substrate stiffness led to slower, more directional migration but did not alter the biochemical markers of EMT. Interestingly, growth factor (i.e., Transforming Growth Factor-β) stimulation resulted in similar levels of EMT regardless of substrate stiffness. We also observed decreased levels of phosphorylated focal adhesion kinase (FAK) and paxillin on stiffer substrates which correlated with slower cell migration. These results indicate that substrate stiffness modulates lung cancer cell migration via focal adhesion signaling as opposed to EMT signaling.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell mechanics; focal adhesions; mechanobiology; tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 26779779     DOI: 10.1002/jbm.a.35655

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  18 in total

1.  Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.

Authors:  Marta Alonso-Nocelo; Theresa M Raimondo; Kyle H Vining; Rafael López-López; Maria de la Fuente; David J Mooney
Journal:  Biofabrication       Date:  2018-03-28       Impact factor: 9.954

2.  Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment.

Authors:  Vasudha C Shukla; Silvia Duarte-Sanmiguel; Ana Panic; Abirami Senthilvelan; Jordan Moore; Christopher Bobba; Brooke Benner; William E Carson; Samir N Ghadiali; Daniel Gallego-Perez
Journal:  Adv Biosyst       Date:  2020-05-18

3.  Behavioral remodeling of normal and cancerous epithelial cell lines with differing invasion potential induced by substrate elastic modulus.

Authors:  Arian Ansardamavandi; Mohammad Tafazzoli-Shadpour; Mohammad Ali Shokrgozar
Journal:  Cell Adh Migr       Date:  2018-08-28       Impact factor: 3.405

4.  How Tumor Cells Can Make Use of Interstitial Fluid Flow in a Strategy for Metastasis.

Authors:  Steinar Evje; Jahn Otto Waldeland
Journal:  Cell Mol Bioeng       Date:  2019-03-27       Impact factor: 2.321

5.  Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.

Authors:  Simion C Dinca; Daniel Greiner; Keren Weidenfeld; Laura Bond; Dalit Barkan; Cheryl L Jorcyk
Journal:  Breast Cancer Res       Date:  2021-05-19       Impact factor: 6.466

6.  Collective tumor cell migration in the presence of fibroblasts.

Authors:  Jahn O Waldeland; William J Polacheck; Steinar Evje
Journal:  J Biomech       Date:  2019-12-19       Impact factor: 2.789

7.  Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells.

Authors:  Takashi Okumura; Kenoki Ohuchida; Masafumi Sada; Toshiya Abe; Sho Endo; Kazuhiro Koikawa; Chika Iwamoto; Daisuke Miura; Yusuke Mizuuchi; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Tatsuya Manabe; Takao Ohtsuka; Eishi Nagai; Kazuhiro Mizumoto; Yoshinao Oda; Makoto Hashizume; Masafumi Nakamura
Journal:  Oncotarget       Date:  2017-03-14

8.  MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.

Authors:  Woda Shi; Jianxiang Song; Wencai Wang; Yajun Zhang; Shiying Zheng
Journal:  Mol Med Rep       Date:  2017-09-19       Impact factor: 2.952

9.  Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.

Authors:  Yohei Ando; Kenoki Ohuchida; Yoshiki Otsubo; Shin Kibe; Shin Takesue; Toshiya Abe; Chika Iwamoto; Koji Shindo; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Yoshinao Oda; Masafumi Nakamura
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

Review 10.  Tissue engineered platforms for studying primary and metastatic neoplasm behavior in bone.

Authors:  Victoria L Thai; Katherine H Griffin; Steven W Thorpe; R Lor Randall; J Kent Leach
Journal:  J Biomech       Date:  2020-12-30       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.